Who Owns Korro Bio Stock?
NASDAQ: KRROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 110.32%
- Institutions (% of float)
- 111.38%
- Held by insiders
- 0.95%
- Institutional holders
- 154
- Institutions 99.0%
- Insiders 1.0%
- Public and other 0.0%
Who owns Korro Bio stock?
Institutional investors own about 110.3% of Korro Bio's shares, spread across 154 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.95% of KRRO.
The largest institutional holders are Lynx1 Capital Management Lp (11.26%), NEA Management Company, LLC (9.46%) and Adage Capital Partners GP L.L.C. (7.29%). Together, the top 10 institutions control 62.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their KRRO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KRRO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Lynx1 Capital Management Lp | 1.54M | 11.26% | +0.4% |
| NEA Management Company, LLC | 1.30M | 9.46% | 0.0% |
| Adage Capital Partners GP L.L.C. | 1.00M | 7.29% | +84.8% |
| Balyasny Asset Management LP | 869.33K | 6.33% | -8.7% |
| Blackrock Inc. | 844.72K | 6.15% | +3.3% |
| Atlas Venture Life Science Advisors, LLC | 773.26K | 5.63% | -19.7% |
| Nantahala Capital Management, LLC | 680.25K | 4.96% | +3.1% |
| Adar1 Capital Management, LLC | 540.05K | 3.93% | 0.0% |
| Affinity Asset Advisors, Llc | 531.90K | 3.88% | -24.8% |
| Vanguard Capital Management LLC | 477.63K | 3.48% | +5.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KRRO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 311.26K | 2.27% |
| iShares Trust-iShares Russell 2000 ETF | 288.56K | 2.10% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 135.40K | 0.99% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 123.99K | 0.90% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | 106.39K | 0.78% |
| iShares Trust-iShares Russell 2000 Value ETF | 82.99K | 0.60% |
| RBB Fund, Inc.-F/m Emerald Life Sciences Innovation ETF | 64.97K | 0.47% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 63.88K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 43.14K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 35.25K | 0.26% |
Frequently asked questions
Who is the largest shareholder of Korro Bio?
Lynx1 Capital Management Lp is the largest institutional shareholder of KRRO, owning 11.26% of shares outstanding (1.54M shares) as of its latest 13F filing.
What percentage of Korro Bio is owned by institutions?
Institutions own about 110.3% of KRRO shares and 111.4% of the public float.
How much of Korro Bio do insiders own?
Insiders, such as officers and directors, own about 0.95% of KRRO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.